Centricity, a New Delhi, India-based wealthtech startup that offers plug-and-play, raised $4 million in pre-seed funding. The round was led by Burman family office, LNJ Bhilwara Group's Shantanu Agarwal, and Polaris Software founder Arun Jain. Other angel investors in the round included Fusion Microfinance's Devesh Sachdev, Devtron Labs' Rajesh Razdan, …

MyCarrier, a Phoenix, AZ-based technology company with a freight shipping platform for small and midsize shippers, announced that it raised $22 million in Series B funding to accelerate SaaS platform expansion beyond LTL/TL for other multimodal shipping needs. The round was led by NewRoad Capital Partners, an operator-led, demand-driven investment …

Verkada, a San Mateo, CA-based market leader in cloud-managed enterprise building security and management, announced a $205 million Series D funding round with new and existing venture partners. The round was led by Linse Capital, with participation from MSD Partners, L.P., and existing investors, including Felicis Ventures, Next47, Sequoia Capital, …

Kojo, a San Francisco, CA-based construction industry's leading materials management platform, announced the completion of its $39 million Series C funding. The round was led by Battery Ventures, with participation from new investors Schneider Electric, RXR, and Bienville Capital. Existing investors, including 8VC, Suffolk Construction, Human Capital, AME, and BoxGroup, …

Chameleon, a San Francisco, CA-based deepest product adoption platform for modern software companies, announced that it raised $13 million in Series A funding to help SaaS companies personalize and customize their UX, thereby improving feature discovery and user engagement. The round was led by Matrix Partners, with General Partner Ilya …

WhiteLab Genomics, a France-based Y-Combinator-backed AI-powered predictive software simulation platform for the design of gene and cell therapies, announced a $10 million funding round. The round was led by Omnes Capital, one of the leading French venture capital firms, and Debiopharm, a Switzerland-based independent biopharmaceutical company with a venture arm …

Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14 million in Series A funding. The round was led by Wellington Partners, joined by existing investors Boehringer Ingelheim Venture Fund (BIVF), …